Inventor · disambiguated record
Irina Y. Shalaurova
Also filed as: SHALAUROVA IRINA · SHALAUROVA IRINA Y
21 granted patents·6 pending applications·127 citations·filing 2002–2024
94Inventor score
Files withLIPOSCIENCE INC27
Top patents by PatentIndex Score
27 records- 0193US6617167B2Method of determining presence and concentration of lipoprotein X in blood plasma and serumLIPOSCIENCE INC·Filed 2002·Granted Sep 9, 2003·61 cites·15 claims
- 0289US9928345B2Multiple-marker risk parameters predictive of conversion to diabetesLIPOSCIENCE INC·Filed 2015·Granted Mar 27, 2018·3 cites·23 claims
- 0388US11231429B2Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameterLIPOSCIENCE INC·Filed 2018·Granted Jan 25, 2022·2 cites·11 claims
- 0488US10388414B2Multi-parameter diabetes risk evaluationsLIPOSCIENCE INC·Filed 2016·Granted Aug 20, 2019·6 cites·20 claims
- 0587US2024302389A1Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction ParameterLIPOSCIENCE INC·Filed 2024·Application pending·0 cites
- 0686US9952232B2Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameterLIPOSCIENCE INC·Filed 2015·Granted Apr 24, 2018·4 cites·22 claims
- 0786US9792410B2Multi-parameter diabetes risk evaluationsLIPOSCIENCE INC·Filed 2013·Granted Oct 17, 2017·10 cites·25 claims
- 0885US10386355B2CHD risk stratification evaluations for subjects with high levels of large HDL-PLIPOSCIENCE INC·Filed 2016·Granted Aug 20, 2019·3 cites·18 claims
- 0985US9361429B2Multi-parameter diabetes risk evaluationsLIPOSCIENCE INC·Filed 2013·Granted Jun 7, 2016·17 cites·52 claims
- 1081US9483612B2CHD risk stratification evaluations for subjects with high levels of large HDL-PLIPOSCIENCE INC·Filed 2013·Granted Nov 1, 2016·4 cites·40 claims
- 1181US2024096497A1Multi-Parameter Diabetes Risk EvaluationsLIPOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1281US2025012820A1Multi-parameter metabolic vulnerability index evaluationsLIPOSCIENCE INC·Filed 2024·Application pending·0 cites
- 1381US2024304336A1Multiple-Marker Risk Parameters Predictive of Conversion to DiabetesLIPOSCIENCE INC·Filed 2024·Application pending·0 cites
- 1480US11988679B2Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameterLIPOSCIENCE INC·Filed 2022·Granted May 21, 2024·0 cites·30 claims
- 1580US11156621B2Multi-parameter metabolic vulnerability index evaluationsLIPOSCIENCE INC·Filed 2018·Granted Oct 26, 2021·2 cites·29 claims
- 1680US9470771B2NMR measurements of NMR biomarker GlycALIPOSCIENCE INC·Filed 2013·Granted Oct 18, 2016·10 cites·8 claims
- 1778US11037683B2Multiple-marker risk parameters predictive of conversion to diabetesLIPOSCIENCE INC·Filed 2018·Granted Jun 15, 2021·1 cites·20 claims
- 1878US9483611B2Protective HDL particle number evaluationsLIPOSCIENCE INC·Filed 2013·Granted Nov 1, 2016·2 cites·18 claims
- 1977US10852293B2NMR measurements of NMR biomarker GlycALIPOSCIENCE INC·Filed 2016·Granted Dec 1, 2020·2 cites·12 claims
- 2075US11990243B2Multiple-marker risk parameters predictive of conversion to diabetesLIPOSCIENCE INC·Filed 2021·Granted May 21, 2024·0 cites·20 claims
- 2174US11703501B2CHD risk stratification evaluations for subjects with high levels of large HDL-PLIPOSCIENCE INC·Filed 2019·Granted Jul 18, 2023·0 cites·20 claims
- 2273US12130295B2NMR system and methods for multi-parameter metabolic vulnerability index evaluationsLIPOSCIENCE INC·Filed 2021·Granted Oct 29, 2024·0 cites·19 claims
- 2369US11692995B2NMR measurements of NMR biomarker GlycALIPOSCIENCE INC·Filed 2020·Granted Jul 4, 2023·0 cites·19 claims
- 2468US11710568B2Multi-parameter diabetes risk evaluationsLIPOSCIENCE INC·Filed 2019·Granted Jul 25, 2023·0 cites·26 claims
- 2567US2023024795A1Methods and Systems to Detect and Quantify the Amount of LP-X and Other Abnormal Lipoproteins in a Biosample Using NMR SpectroscopyLIPOSCIENCE INC·Filed 2022·Application pending·0 cites
- 2661US11467171B2Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopyLIPOSCIENCE INC·Filed 2018·Granted Oct 11, 2022·0 cites·20 claims
- 2745US2022011388A1Methods to predict liver disease mortality using lipoprotein lp-zLIPOSCIENCE INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →